Unlock instant, AI-driven research and patent intelligence for your innovation.

Polyethylene glycol derivatives of activated lactone compounds

A technology of PEGylation and compounding, which is applied in the field of active lactone compounds, and can solve problems such as the influence of drug stability

Inactive Publication Date: 2012-02-29
INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Traditional Chuanhuning injection needs to be sterilized by high temperature and high pressure, which is easy to degrade the drug and affect the stability of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polyethylene glycol derivatives of activated lactone compounds
  • Polyethylene glycol derivatives of activated lactone compounds
  • Polyethylene glycol derivatives of activated lactone compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 Using penhuning as the starting material to prepare single-site mPEG of dehydroandrographolide disuccinic acid half ester 1100 derivative.

[0040]

[0041] Weigh 2.85g (5mmol) of Chuanhuning and place it in a 500ml reaction bottle, add a mixed solution of 125ml ethanol and 175ml water, after the solid dissolves, add 5.0ml of 1M HC1 aqueous solution dropwise under ice bath conditions, and stir for 10 minutes after the addition is completed. minutes, room temperature (25 ° C) rotary evaporation to remove a large amount of ethanol, extracted with ethyl acetate, dried with anhydrous sodium sulfate, rotary evaporation to remove the solvent, quantitatively obtained dehydroandrographolide disuccinic acid half ester 2.60g.

[0042] Dissolve 2.6g (5mmol) dehydroandrographolide disuccinic acid half ester in 100ml DCM, add 1.95g EDC·HCl (10mmol) to dissolve, stir for 10 minutes, then add 8.25gmPEG 1100 (7.5 mmol). Under ice-bath conditions, 0.061 g DMAP (0.5 mmol) ...

Embodiment 2

[0043] Example 2 Using dehydroandrographolide disuccinate half ester as a starting material to prepare single-site mPEG of dehydroandrographolide disuccinate half ester 1100 derivative.

[0044] Dissolve 2.53g (5mmol) dehydroandrographolide disuccinic acid half ester in 100ml DCM, add 1.95g EDC·HCl (10mmol) to dissolve, stir for 10 minutes, then add 8.25gmPEG 1100 (7.5 mmol). Under ice-bath conditions, 0.061 g DMAP (0.5 mmol) was added. After reacting for 5 hours, after the completion of the reaction was monitored by HPLC, the reaction solution was concentrated and subjected to silica gel column chromatography to obtain a light yellow oily liquid, and a white solid was precipitated with anhydrous ether to obtain 4.42 g of the product, with a yield of 54.2%.

Embodiment 3

[0045] Example 3 Preparation of double-site mPEG of dehydroandrographolide disuccinic acid half-ester using penhuning as starting material 1100 derivative.

[0046]

[0047] Weigh 2.85g (5mmol) of Chuanhuning and place it in a 500ml reaction bottle, add a mixed solution of 125ml ethanol and 175ml water, after the solid dissolves, add 5.0ml 1M aqueous HCl solution dropwise under ice bath conditions, and stir for 10 minutes after the addition is completed. minutes, room temperature (25 ° C) rotary evaporation to remove a large amount of ethanol, extracted with ethyl acetate, dried with anhydrous sodium sulfate, rotary evaporation to remove the solvent, quantitatively obtained dehydroandrographolide disuccinic acid half ester 2.60g.

[0048] Dissolve 2.6g (5mmol) dehydroandrographolide disuccinic acid half ester in 100ml DCM, add 2.14g EDC·HCl (11mmol) to dissolve, stir for 10 minutes, then add 12.12g mPEG 1100 (11 mmol). Under ice-bath conditions, 0.061 g DMAP (0.5 mmol) wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to polyethylene glycol derivatives of activated lactone compounds, a preparation method thereof, a medicine composition containing the polyethylene glycol derivatives and application of the medicine composition in the aspects of bacteria and eliminating inflammation, killing pains, resisting viruses and the like.

Description

field of invention [0001] The invention relates to an active lactone compound, especially a pegylated conjugate of andrographolide and its derivatives, and its use in the preparation of drugs with related functions such as antibacterial, anti-inflammatory, analgesic, and antiviral. Background technique [0002] Andrographolide (andrographolide) is a diterpene lactone compound extracted from the Acanthaceae plant Andrographis paniculata. It is one of the main active ingredients of the traditional Chinese medicine Andrographis paniculata, and the content in the leaves of Andrographis paniculata is as high as 1.84%. Mass production of raw materials for antipyretic and analgesic drugs such as liquid medicine. Modern pharmacological studies have shown that andrographolide and its dehydroandrographolide, deoxyandrographolide and other derivatives have anti-inflammatory, anti-bacterial, anti-virus, anti-tumor, immune regulation, treatment of cardiovascular and cerebrovascular disea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D307/58A61K47/60
Inventor 刘克良李思成乔磊冯思良全东琴贾启燕孟庆斌韩寒
Owner INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A